Therapy Areas: Cardiovascular
8 November 2018 - Myovant Sciences Ltd (NYSE: MYOV), a clinical-stage biopharmaceutical company focused on developing and commercialising innovative therapies for women's health and endocrine dis...
7 November 2018 - AstraZeneca plc (LSE:AZN), a global, science-led biopharmaceutical company, announced on Tuesday that it has entered into an agreement with Covis Pharma B.V (Covis Pharma), a special...
5 November 2018 - - Initial results from EMPRISE real-world evidence study shows empagliflozin was associated with reduced risk for hospitalisation for heart failure compared with DPP-4 inhibitors in ...
5 November 2018 - Danish biotech company Acesion Pharma, a developer of novel treatments for atrial fibrillation (AF), on Monday declared positive results from the Phase 1 clinical trial of AP30663, a...
2 November 2018 - - German biopharmaceutical company Omeicos Therapeutics has closed a EUR 17m (approx. 19.5m) Series C financing led by new investor Forbion, the company said.

Existing i...
2 November 2018 - - France-based cell therapy product developer CellProThera and US-based regenerative biologic therapies developer BioCardia (OTC: BCDA) have inked an agreement to expand their c...
Related Headlines